Is QUTIF or MRK a better dividend investment in 2026?

QUTIF currently yields 790.51% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: QUTIF offers higher current income.

What is the dividend yield difference between QUTIF and MRK?

QUTIF has a forward dividend yield of 790.51% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 787.75 percentage points.

Home › Compare › QUTIF vs MRK

QUTIF vs MRK: Dividend Comparison 2026

QUTIF yields 790.51% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QUTIF wins by $2508222.42M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QUTIF

● Live price

790.51%

Share price

$0.25

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$2508222.48M

Annual income

$2,008,434,345,350.19

Full QUTIF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — QUTIF vs MRK

📍 QUTIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QUTIF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QUTIF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QUTIF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QUTIF

Annual income on $10K today (after 15% tax)

$67,193.68/yr

After 10yr DRIP, annual income (after tax)

$1,707,169,193,547.66/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, QUTIF beats the other by $1,707,169,185,219.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QUTIF + MRK for your $10,000?

QUTIF: 50%MRK: 50%

100% MRK50/50100% QUTIF

Portfolio after 10yr

$1254111.27M

Annual income

$1,004,217,177,574.17/yr

Blended yield

80.07%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

QUTIF

No analyst data

Altman Z

3.2

Piotroski

5/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QUTIF buys

MRK buys

No recent congressional trades found for QUTIF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQUTIFMRK

Forward yield	790.51% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$2508222.48M ✓	$56.8K
Annual income after 10y	$2,008,434,345,350.19 ✓	$9,798.13
Total dividends collected	$2468620.16M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: QUTIF vs MRK ($10,000, DRIP)

Year	QUTIF Portfolio	QUTIF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$89,751	$79,051.38	$11,206	$366.19	+$78.5K → QUTIF
2	$759,115	$663,081.40	$12,650	$502.35	+$746.5K → QUTIF
3	$6,053,683	$5,241,429.06	$14,407	$694.19	+$6.04M → QUTIF
4	$45,541,537	$39,064,096.33	$16,585	$967.82	+$45.52M → QUTIF
5	$323,380,988	$274,651,543.39	$19,342	$1,363.89	+$323.36M → QUTIF
6	$2,168,675,165	$1,822,657,508.70	$22,913	$1,947.19	+$2168.65M → QUTIF
7	$13,744,038,415	$11,423,555,987.76	$27,662	$2,823.89	+$13744.01M → QUTIF
8	$82,366,962,015	$67,660,840,910.91	$34,159	$4,173.35	+$82366.93M → QUTIF
9	$467,091,715,031	$378,959,065,675.17	$43,337	$6,308.80	+$467091.67M → QUTIF
10	$2,508,222,480,433	$2,008,434,345,350.19	$56,776	$9,798.13	+$2508222.42M → QUTIF

QUTIF vs MRK: Complete Analysis 2026

QUTIF — Stock

Questor Technology Inc., an environmental emissions reduction technology company, designs, manufactures, and services waste gas combustion systems in Canada and the United States. The company rents waste gas incineration systems. It offers its solutions for various oil and gas projects, as well as for landfill biogas, syngas, waste engine exhaust, geothermal and solar, and cement plant waste heat. The company was formerly known as Interglobe Gas Technology Inc. and changed its name to Questor Technology Inc. in September 1995. Questor Technology Inc. was founded in 1994 and is headquartered in Calgary, Canada.

Full QUTIF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this QUTIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QUTIF vs SCHD QUTIF vs JEPI QUTIF vs O QUTIF vs KO QUTIF vs MAIN QUTIF vs JNJ QUTIF vs ABBV QUTIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.